KORRO BIO INC (KRRO) Fundamental Analysis & Valuation

NASDAQ:KRRO • US5009461089

Current stock price

13.47 USD
-0.21 (-1.54%)
At close:
13.47 USD
0 (0%)
After Hours:

This KRRO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. KRRO Profitability Analysis

1.1 Basic Checks

  • KRRO had negative earnings in the past year.
  • In the past year KRRO has reported a negative cash flow from operations.
  • KRRO had negative earnings in each of the past 5 years.
  • KRRO had a negative operating cash flow in each of the past 5 years.
KRRO Yearly Net Income VS EBIT VS OCF VS FCFKRRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

  • With a Return On Assets value of -103.31%, KRRO is not doing good in the industry: 76.94% of the companies in the same industry are doing better.
  • KRRO has a worse Return On Equity (-227.96%) than 71.90% of its industry peers.
Industry RankSector Rank
ROA -103.31%
ROE -227.96%
ROIC N/A
ROA(3y)-58.96%
ROA(5y)-54.56%
ROE(3y)-109.28%
ROE(5y)-87.08%
ROIC(3y)N/A
ROIC(5y)N/A
KRRO Yearly ROA, ROE, ROICKRRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for KRRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KRRO Yearly Profit, Operating, Gross MarginsKRRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. KRRO Health Analysis

2.1 Basic Checks

  • KRRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, KRRO has more shares outstanding
  • Compared to 5 years ago, KRRO has less shares outstanding
  • KRRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
KRRO Yearly Shares OutstandingKRRO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
KRRO Yearly Total Debt VS Total AssetsKRRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • KRRO has an Altman-Z score of -4.57. This is a bad value and indicates that KRRO is not financially healthy and even has some risk of bankruptcy.
  • KRRO's Altman-Z score of -4.57 is on the low side compared to the rest of the industry. KRRO is outperformed by 62.98% of its industry peers.
  • There is no outstanding debt for KRRO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.57
ROIC/WACCN/A
WACC9.16%
KRRO Yearly LT Debt VS Equity VS FCFKRRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • KRRO has a Current Ratio of 6.90. This indicates that KRRO is financially healthy and has no problem in meeting its short term obligations.
  • KRRO has a better Current ratio (6.90) than 66.47% of its industry peers.
  • A Quick Ratio of 6.90 indicates that KRRO has no problem at all paying its short term obligations.
  • KRRO's Quick ratio of 6.90 is fine compared to the rest of the industry. KRRO outperforms 66.86% of its industry peers.
Industry RankSector Rank
Current Ratio 6.9
Quick Ratio 6.9
KRRO Yearly Current Assets VS Current LiabilitesKRRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. KRRO Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.28% over the past year.
  • Looking at the last year, KRRO shows a very strong growth in Revenue. The Revenue has grown by 181.46%.
  • The Revenue for KRRO have been decreasing by -29.61% on average. This is quite bad
EPS 1Y (TTM)6.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.99%
Revenue 1Y (TTM)181.46%
Revenue growth 3YN/A
Revenue growth 5Y-29.61%
Sales Q2Q%-43.11%

3.2 Future

  • KRRO is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -9.27% yearly.
  • Based on estimates for the next years, KRRO will show a very strong growth in Revenue. The Revenue will grow by 43.85% on average per year.
EPS Next Y23.85%
EPS Next 2Y10.01%
EPS Next 3Y3.9%
EPS Next 5Y-9.27%
Revenue Next Year-58.36%
Revenue Next 2Y-60.84%
Revenue Next 3Y-25.99%
Revenue Next 5Y43.85%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KRRO Yearly Revenue VS EstimatesKRRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2024 2025 2026 2027 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
KRRO Yearly EPS VS EstimatesKRRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -20 -40 -60 -80 -100

More info and screens

Find the best growth stocksShow best growing peers

0

4. KRRO Valuation Analysis

4.1 Price/Earnings Ratio

  • KRRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KRRO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KRRO Price Earnings VS Forward Price EarningsKRRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KRRO Per share dataKRRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.01%
EPS Next 3Y3.9%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KRRO Dividend Analysis

5.1 Amount

  • KRRO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KRRO Fundamentals: All Metrics, Ratios and Statistics

KORRO BIO INC

NASDAQ:KRRO (4/16/2026, 8:00:02 PM)

After market: 13.47 0 (0%)

13.47

-0.21 (-1.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-12
Earnings (Next)05-05
Inst Owners78.69%
Inst Owner Change0.02%
Ins Owners1.28%
Ins Owner Change21%
Market Cap194.24M
Revenue(TTM)6.39M
Net Income(TTM)-117.26M
Analysts80
Price Target19.53 (44.99%)
Short Float %7.75%
Short Ratio4.86
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.59%
Min EPS beat(2)21.74%
Max EPS beat(2)27.43%
EPS beat(4)3
Avg EPS beat(4)12.66%
Min EPS beat(4)-4.75%
Max EPS beat(4)27.43%
EPS beat(8)7
Avg EPS beat(8)10.21%
EPS beat(12)9
Avg EPS beat(12)-73.26%
EPS beat(16)12
Avg EPS beat(16)-52.65%
Revenue beat(2)2
Avg Revenue beat(2)109.69%
Min Revenue beat(2)84.81%
Max Revenue beat(2)134.57%
Revenue beat(4)4
Avg Revenue beat(4)198.88%
Min Revenue beat(4)84.81%
Max Revenue beat(4)394.73%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-57.46%
EPS NQ rev (1m)15.02%
EPS NQ rev (3m)12.92%
EPS NY rev (1m)18.34%
EPS NY rev (3m)15.26%
Revenue NQ rev (1m)21.68%
Revenue NQ rev (3m)1.4%
Revenue NY rev (1m)29.29%
Revenue NY rev (3m)3.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 30.39
P/FCF N/A
P/OCF N/A
P/B 3.78
P/tB 3.78
EV/EBITDA N/A
EPS(TTM)-8.8
EYN/A
EPS(NY)-6.7
Fwd EYN/A
FCF(TTM)-5.48
FCFYN/A
OCF(TTM)-5.45
OCFYN/A
SpS0.44
BVpS3.57
TBVpS3.57
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -103.31%
ROE -227.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-58.96%
ROA(5y)-54.56%
ROE(3y)-109.28%
ROE(5y)-87.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.1%
Cap/Sales 8.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.9
Quick Ratio 6.9
Altman-Z -4.57
F-Score4
WACC9.16%
ROIC/WACCN/A
Cap/Depr(3y)243.38%
Cap/Depr(5y)233.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.99%
EPS Next Y23.85%
EPS Next 2Y10.01%
EPS Next 3Y3.9%
EPS Next 5Y-9.27%
Revenue 1Y (TTM)181.46%
Revenue growth 3YN/A
Revenue growth 5Y-29.61%
Sales Q2Q%-43.11%
Revenue Next Year-58.36%
Revenue Next 2Y-60.84%
Revenue Next 3Y-25.99%
Revenue Next 5Y43.85%
EBIT growth 1Y4.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.77%
OCF growth 3YN/A
OCF growth 5YN/A

KORRO BIO INC / KRRO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for KORRO BIO INC?

ChartMill assigns a fundamental rating of 3 / 10 to KRRO.


Can you provide the valuation status for KORRO BIO INC?

ChartMill assigns a valuation rating of 0 / 10 to KORRO BIO INC (KRRO). This can be considered as Overvalued.


How profitable is KORRO BIO INC (KRRO) stock?

KORRO BIO INC (KRRO) has a profitability rating of 0 / 10.


Can you provide the financial health for KRRO stock?

The financial health rating of KORRO BIO INC (KRRO) is 7 / 10.